
|Articles|April 1, 2003
- Pharmaceutical Executive-04-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 23 years ago
In the Eye of the Stormalmost 23 years ago
Pharma WANTS YOUalmost 23 years ago
What They're Not Sayingalmost 23 years ago
Generic Treatment Claims: Do They Hold Water?almost 23 years ago
Generics Battle Heats Upalmost 23 years ago
HBA's 2003 Woman of the YearNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report
2
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
3
TrumpRx Is Live and Complicated
4
Novo Nordisk Launches First Super Bowl Commercial for Wegovy Pill
5




